Cite
HARVARD Citation
Matos Garcia, I. et al. (n.d.). 110PImmune prognostic index (IPI) and hyper-progressive disease (HPD) in patients (pts) exposed to targeted agents (TAs) in phase I trials (Ph1T): Can lessons from immune checkpoint inhibitors (ICIs) be translated to other scenarios?. Annals of oncology. p. . [Online].